Silence Therapeutics PLCNASDAQ:SLN
No Matches were found for
- LAST PRICE20.9900
- TODAY'S CHANGE (%)-0.0300 (-0.1427%)
- Bid / Lots21.0000/ 3
- Ask / Lots24.0000/ 2
- Open / Previous Close21.9200 / 21.0200
- Day Range
- 52 Week Range
- Volume355,351
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SLN |
|---|---|---|
| 09:32 ET | 4907 | 21.99 |
| 09:34 ET | 4753 | 21.49 |
| 09:38 ET | 7580 | 21.5 |
| 09:39 ET | 230 | 21.8737 |
| 09:41 ET | 100 | 21.305 |
| 09:43 ET | 100 | 21.26 |
| 09:45 ET | 459 | 21.325 |
| 09:48 ET | 1000 | 21.49 |
| 09:52 ET | 300 | 21.34 |
| 09:54 ET | 300 | 21.37 |
| 09:57 ET | 917 | 21.2 |
| 09:59 ET | 7820 | 20.87 |
| 10:01 ET | 200 | 20.935 |
| 10:06 ET | 100 | 21.035 |
| 10:08 ET | 450 | 20.85 |
| 10:10 ET | 100 | 21.055 |
| 10:12 ET | 200 | 21.05 |
| 10:14 ET | 100 | 21.05 |
| 10:15 ET | 2300 | 21.01 |
| 10:19 ET | 355 | 21.035 |
| 10:30 ET | 1273 | 21.11 |
| 10:32 ET | 100 | 21.07 |
| 10:33 ET | 100 | 21.1 |
| 10:35 ET | 114 | 21.105 |
| 10:37 ET | 100 | 21.02 |
| 10:42 ET | 100 | 21.11 |
| 10:50 ET | 2000 | 21 |
| 10:51 ET | 1400 | 20.945 |
| 10:53 ET | 1848 | 20.87 |
| 10:55 ET | 5913 | 21.0199 |
| 10:57 ET | 1900 | 21 |
| 11:00 ET | 200 | 21.015 |
| 11:02 ET | 100 | 20.895 |
| 11:06 ET | 500 | 21.0178 |
| 11:08 ET | 100 | 20.91 |
| 11:09 ET | 100 | 20.945 |
| 11:13 ET | 200 | 21 |
| 11:18 ET | 100 | 21.1675 |
| 11:20 ET | 2600 | 20.995 |
| 11:22 ET | 140 | 20.93 |
| 11:26 ET | 1200 | 21 |
| 11:27 ET | 100 | 21.045 |
| 11:29 ET | 2793 | 20.925 |
| 11:31 ET | 2490 | 20.92 |
| 11:33 ET | 200 | 20.97 |
| 11:42 ET | 1490 | 21.02 |
| 11:44 ET | 100 | 21.005 |
| 11:51 ET | 100 | 21.195 |
| 11:54 ET | 600 | 21.08 |
| 11:56 ET | 280 | 21.2099 |
| 11:58 ET | 3160 | 21.04 |
| 12:00 ET | 150 | 21 |
| 12:02 ET | 2300 | 21 |
| 12:07 ET | 100 | 20.9 |
| 12:09 ET | 100 | 21 |
| 12:12 ET | 4310 | 21 |
| 12:14 ET | 100 | 21.04 |
| 12:18 ET | 200 | 21.05 |
| 12:23 ET | 200 | 21 |
| 12:43 ET | 4990 | 21 |
| 12:45 ET | 100 | 21.01 |
| 12:48 ET | 100 | 21.05 |
| 12:50 ET | 100 | 21.05 |
| 12:56 ET | 10500 | 21.045 |
| 12:57 ET | 200 | 21.005 |
| 12:59 ET | 1500 | 21 |
| 01:01 ET | 1100 | 20.91 |
| 01:06 ET | 5000 | 20.92 |
| 01:10 ET | 4900 | 21 |
| 01:14 ET | 5100 | 21 |
| 01:17 ET | 100 | 20.93 |
| 01:21 ET | 100 | 21 |
| 01:24 ET | 653 | 20.9835 |
| 01:26 ET | 100 | 20.97 |
| 01:28 ET | 100 | 20.97 |
| 01:30 ET | 50000 | 21 |
| 01:32 ET | 100 | 21 |
| 01:46 ET | 200 | 21 |
| 01:50 ET | 300 | 21.02 |
| 01:55 ET | 100 | 21.025 |
| 02:06 ET | 100 | 21 |
| 02:13 ET | 500 | 21.02 |
| 02:15 ET | 100 | 21.025 |
| 02:27 ET | 100 | 21.035 |
| 02:38 ET | 5467 | 21 |
| 02:40 ET | 200 | 20.99 |
| 02:44 ET | 100 | 20.99 |
| 02:47 ET | 1900 | 20.935 |
| 02:54 ET | 100 | 21.005 |
| 02:56 ET | 2700 | 20.935 |
| 03:02 ET | 100 | 21.005 |
| 03:07 ET | 209 | 20.87 |
| 03:12 ET | 100 | 21 |
| 03:18 ET | 300 | 21 |
| 03:20 ET | 100 | 21 |
| 03:21 ET | 335 | 21.005 |
| 03:23 ET | 100 | 21 |
| 03:25 ET | 523 | 21.01 |
| 03:27 ET | 100 | 21.02 |
| 03:32 ET | 25405 | 21 |
| 03:34 ET | 400 | 20.94 |
| 03:38 ET | 1700 | 21 |
| 03:39 ET | 984 | 20.993 |
| 03:41 ET | 300 | 20.99 |
| 03:45 ET | 500 | 21 |
| 03:52 ET | 1723 | 20.99 |
| 03:54 ET | 400 | 20.955 |
| 03:56 ET | 676 | 20.905 |
| 03:57 ET | 2375 | 20.895 |
| 03:59 ET | 1342 | 20.99 |
Jun 28, 2024
DJ Silence Therapeutics Is Maintained at Overweight by Morgan Stanley, from 11:59AM ET on Friday Jun 28, 2024 by Dow Jones
11:59AM ET on Friday Jun 28, 2024 by Dow JonesDJ Silence Therapeutics Is Maintained at Buy by Chardan Capital, from 8:29AM ET on Friday Jun 28, 2024 by Dow Jones
8:29AM ET on Friday Jun 28, 2024 by Dow Jones
Jun 27, 2024
DJ Silence Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co., from 12:17PM ET on Thursday Jun 27, 2024 by Dow Jones
12:17PM ET on Thursday Jun 27, 2024 by Dow JonesSilence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients, from 7:30AM ET on Thursday Jun 27, 2024 by Dow Jones
7:30AM ET on Thursday Jun 27, 2024 by Dow Jones
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
